verapamil has been researched along with trandolapril in 151 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 48 (31.79) | 18.2507 |
| 2000's | 75 (49.67) | 29.6817 |
| 2010's | 25 (16.56) | 24.3611 |
| 2020's | 3 (1.99) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Küng, CF; Lüscher, TF; Moreau, P; Schaffner, T; Takase, H; van Rooijen, MM | 1 |
| Küng, CF; Lüscher, TF; Moreau, P; Takase, H | 2 |
| Lang, MG; Lüscher, TF; Noll, G; Novosel, D | 1 |
| Boehm, EA; Clark, JF; Leighton, B; Radda, GK; Sanderson, AL; Young, ME | 1 |
| Küng, CF; Lüscher, TF; Moreau, P; Nava, E; Takase, H | 1 |
| Dietze, GJ; Fogt, DL; Henriksen, EJ; Jacob, S | 1 |
| Hansen, JF; Jespersen, CM; Madsen, JK; Rasmussen, V; Tingsted, L | 1 |
| Hergenröder, S; Jochims, K; Kirchengast, M; Münter, K | 1 |
| Boehlen, L; Buechel, P; Lerch, M; Papiri, M; Risen, W; Schneider, M; Shaw, S; Weidmann, P | 1 |
| Oren, S; Viskoper, JR; Zilles, P | 1 |
| Boulanger, CM; Kirchengast, M; Lee, JJ; Vanhoutte, PM | 1 |
| de Leeuw, PW; Notter, T; Zilles, P | 1 |
| Hagerup, L; Hansen, JF; Mellemgaard, K; Mortensen, LS; Pedersen, F; Pedersen-Bjergaard, O; Sigurd, B | 1 |
| Aepfelbacher, FC; Messerli, FH; Michalewicz, L; Nunez, E | 1 |
| DeQuattro, V; Lee, D; Messerli, F | 1 |
| Hlatswayo, Z; Radevski, I; Sareli, P; Skoularigis, J; Strugo, V | 1 |
| Kirchengast, M | 1 |
| Holzgreve, H | 1 |
| Hagerup, L; Hansen, JF; Mellemgaard, K; Pedersen, F; Pedersen-Bjergaard, O; Sigurd, B | 1 |
| DeQuattro, V; Lee, D | 1 |
| Grassi, G; Mancia, G; Omboni, S | 1 |
| Bjergaard, OP; Hagerup, L; Hansen, JF; Mellemgaard, K; Pedersen, F; Sigurd, B | 1 |
| Novrit, BA; Punzi, HA | 1 |
| Clark, JF; Leighton, B; Young, ME | 1 |
| Flores, O; Gallego, B; López-Novoa, JM; Pérez-Barriocanal, F | 1 |
| González, JD; Llinás, MT; Nava, E; Rodríguez, F; Salazar, FJ; Taddei, S | 1 |
| Streier, K | 1 |
| Hansen, JF | 1 |
| Remuzzi, G; Ruggenenti, P | 1 |
| Elliott, WJ; Frishman, WH; Messerli, F | 1 |
| Compagnone, D; Scholze, J; Zilles, P | 1 |
| Carrón, R; Flores, O; López-Hernández, FJ; López-Novoa, JM; Montero, MJ | 1 |
| Belz, GG; Breithaupt-Grögler, K; Gerhardt, G; Lehmann, G; Notter, T | 1 |
| Bakris, GL; DeQuattro, V; McMahon, FG; Weir, MR | 1 |
| Conlon, M; Cooper-DeHoff, R; Handberg-Thurmond, E; Marks, RG; Pepine, CJ; Volkers, P; Zellig, P | 1 |
| Dzúrik, R; Widimský, J | 1 |
| Dooley, M; Goa, KL | 1 |
| Benetos, A; Kirchengaast, M; Koffi, I; Lacolley, P; Laurent, S; Pomiès, JP | 1 |
| Makolkin, VI; Podzolkov, VI | 1 |
| Kraljevic, V; McCarthy, J; Muller, CA; Opie, LH; Pineda, CA | 1 |
| Compagnone, D; Holzgreve, H; Zilles, P | 1 |
| de Jong, PE; de Zeeuw, D; Hemmelder, MH | 1 |
| Arévalo, MA; Carrón, R; Flores, O; López-Hernández, FJ; López-Novoa, JM; Montero, MJ | 1 |
| Asmar, R; Bacri, AM; Benetos, A; Rudnicki, A; Safar, ME; Sayegh, F; Topouchian, J | 1 |
| Gómez Guindal, JA; González Lama, I; González Maqueda, I | 1 |
| Coca, A; de la Cámara, AG; de la Figuera, M; de la Sierra, A; Fernández, R; Garrido, J; Luque-Otero, M; Moreno, E; Ruilope, LM | 1 |
| Carrón, R; López-Hernández, FJ; Montero, MJ | 1 |
| Asmar, R; Bean, K; Benetos, A; Guize, L; Rudnichi, A; Safar, M | 1 |
| Andrup, M; Karlberg, BE; Odén, A | 1 |
| Cifková, R; Compagnone, D; Hejl, Z; Nakov, R; Novozámská, E; Petrzílková, Z; Poledne, R; Stávek, P | 1 |
| Boehm, EA; Clark, JF; Radda, GK | 1 |
| Guelpa, G | 1 |
| Duru, M; Gokel, Y; Paydas, S | 1 |
| Widimský, J | 1 |
| Dall'Anese, C; García de Vinuesa, S; Gómez-Campderá, F; Luño, J; Ridao, N; Sánchez, M; Valderrábano, F | 1 |
| Cominacini, L; Ferrannini, E; Franzoni, F; Fratta-Pasini, A; Galetta, F; Garbin, U; Natali, A; Pucciarelli, A; Quiñones-Galvan, A | 1 |
| Fernández, R; Garrido, J; Puig, JG; Redon, J; Rodríguez-Pérez, JC | 1 |
| Armenteros, S; Fernández González, R; Garrido, J; Goicolea, I; Martínez, JM; Moreno Carretero, E; Piniés, J | 1 |
| Curran, MP; Muijsers, RB; Perry, CM | 1 |
| Cech, F; Rosolová, H; Sefrna, F | 1 |
| Ciociaro, D; Ferrannini, E; Franzoni, F; Masoni, A; Natali, A; Pucciarelli, A; Quiñones-Galvan, A | 1 |
| Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L | 1 |
| Acikalin, A; Bozkurt, A; Gokel, Y; Paydas, S | 1 |
| Beck, K; Holzgreve, H; Janka, HU; Nakov, R | 1 |
| Berto, IM; Boero, R; Lanfranco, G; Massara, C; Perosa, P; Quarello, F; Rollino, C; Vagelli, G | 1 |
| Guay, DR | 1 |
| Bustamante, J; Calvo, C; Fernández, R; Garay, R; Grande, J; Herrera, J; López-Novoa, JM; Macías-Núñez, JF; Robles, R | 1 |
| Bakris, GL; Bristol, HA; Cangiano, JL; Cohen, JD; Cooper-DeHoff, RM; Erdine, S; Garcia-Barreto, D; Handberg, EM; Keltai, M; Kolb, HR; Kowey, P; Mancia, G; Marks, RG; Messerli, FH; Parmley, WW; Pepine, CJ | 1 |
| Bakris, GL; Ruilope, LM; Segura, J; Usan, L | 1 |
| Flack, JM | 1 |
| Liebson, PR | 1 |
| Martynov, AI; Shestakova, MV; Sidorenko, BA; Ugriumova, MO; Zadionchenko, VS | 1 |
| Arceo-Navarro, A; Gomez-Harper, CT; Lozano-Nuevo, JJ; Rodriguez-Lopez, L; Rubio-Guerra, AF; Vargas-Ayala, G | 1 |
| Conti, CR; Pepine, CJ | 1 |
| Bakris, GL; Cooper-DeHoff, R; Erdine, S; Gaxiola, E; Mancia, G; Messerli, FH; Pepine, CJ | 1 |
| Arnoldi, F; Bossi, A; Bruno, S; Brusegan, V; Dodesini, AR; Ene-Iordache, B; Fassi, A; Ganeva, M; Gaspari, F; Gherardi, G; Iliev, IP; Ilieva, AP; Perna, A; Remuzzi, G; Rubis, N; Ruggenenti, P; Trevisan, R | 1 |
| Diethelm, M; Joerger, M | 1 |
| Logan, A | 1 |
| Gurevich, MA | 1 |
| Arant, CB; Cooper-Dehoff, RM; Geiser, EA; Pepine, CJ; Sleight, P; Wessel, TR; Zineh, I | 1 |
| Keam, SJ; Reynolds, NA; Wagstaff, AJ | 1 |
| Cooper-DeHoff, R; Elliott, WJ; Hewkin, AC; Kupfer, S; Pepine, CJ | 1 |
| Karpov, IuA | 1 |
| Benetos, A; Coca, A; Conti, CR; Cooper-DeHoff, RM; Gaxiola, E; Handberg, E; Hewkin, AC; Kolloch, RE; Kowey, PR; Kupfer, S; Mancia, G; Pepine, CJ; Sleight, P; Tavazzi, L | 1 |
| Aranda, JM; Cangiano, JL; Conti, CR; Cooper-DeHoff, RM; Garcia-Barreto, D; Gaxiola, E; Hewkin, A; Pepine, CJ | 1 |
| Bakris, GL; Cohen, JD; Cooper-Dehoff, R; Erdine, S; Hewkin, AC; Kupfer, S; Messerli, FH; Pepine, CJ | 1 |
| Escalante-Acosta, BA; Lozano-Nuevo, JJ; Ramos-Brizuela, LM; Rodríguez-López, L; Rubio-Guerra, AF; Vargas-Ayala, G | 1 |
| Ene-Iordache, B; Ganeva, M; Perna, A; Remuzzi, G; Ruggenenti, P | 1 |
| Glassock, RJ | 1 |
| Bacher, P; Bakris, G; Fakouhi, K; Hewkin, A; Kipnes, M; Molitch, M; Sarafidis, P; Sowers, J | 1 |
| Grimm, E; Herrmann, D; Kintscher, U; Scholze, J; Unger, T | 1 |
| Assouline, L; Burgess, ED; Tytus, RH; Vanjaka, A | 1 |
| Batalis, NI; Harley, RA; Schandl, CA | 1 |
| Brunner, M; Cooper-DeHoff, RM; Gong, Y; Johnson, JA; Karnes, JH; Langaee, TY; Pepine, CJ | 1 |
| Bacher, PH; Elliott, WJ; Frishman, WH; Messerli, F; Pepine, CJ | 1 |
| García Donaire, JA; Ruilope, LM | 1 |
| Bakris, G; Champion, A; Mancia, G; Messerli, F; Pepine, CJ; Zhou, Q | 1 |
| Beitelshees, AL; Cooper-Dehoff, RM; Gong, Y; Johnson, JA; Knot, HJ; Langaee, TY; Pepine, CJ; Sadee, W; Schork, NJ; Shriver, MD; Wang, D | 1 |
| Remuzzi, G; Ruggenenti, P; Sharma, SK | 1 |
| Benetos, A; Champion, A; Coca, A; Cooper-DeHoff, RM; Messerli, FH; Pepine, CJ; Zhou, Q | 1 |
| Kobalava, ZhD; Kotovskaia, IuV | 1 |
| Braam, RL; Lenders, JW; Thien, T; van Uum, SH | 1 |
| Bacher, P; Bakris, G; Champion, A; Molitch, M; Sarafidis, P; Sowers, JR; Zhou, Q | 1 |
| Champion, A; Cooper-Dehoff, RM; Handberg, E; Kolloch, R; Legler, UF; Pepine, CJ; Zhou, Q | 1 |
| Feihl, F; Gojanovic, B; Liaudet, L; Waeber, B | 1 |
| Elisaf, MS; Filippatos, TD; Kiortsis, DN; Liberopoulos, EN; Mikhailidis, DP; Nakou, E; Tselepis, AD | 1 |
| Bacher, PH; Bangalore, S; Champion, A; Cohen, JD; Kowey, P; Mancia, G; Messerli, FH; Pepine, CJ; Sleight, P; Zhou, Q | 1 |
| Escalante-Acosta, BA; Rodriguez-Lopez, L; Rubio-Guerra, AF; Vargas-Ayala, G; Vargas-Robles, H | 1 |
| Abakumov, IuE; Ostroumova, OD; Otdelenov, AV; Paukov, SV; Zhukova, OV | 1 |
| Bacher, P; Champion, A; Fakouhi, K; Tian, M; Toto, RD | 1 |
| Daghini, E; Duranti, E; Ghiadoni, L; Magagna, A; Masi, S; Taddei, S; Versari, D; Virdis, A | 1 |
| Aranda, JM; Champion, A; Cooper-Dehoff, RM; Denardo, SJ; Gaxiola, E; Gong, Y; Handberg, EM; Messerli, FH; Pepine, CJ; Zhou, Q | 1 |
| Cohen, V; Fancher, L; Farahani, C; Jellinek, SP; Marquart, E; Sangwan, G; Wakslak, M | 1 |
| Cooper-Dehoff, RM; Gerhard, T; Gong, Y; Handberg, EM; Johnson, JA; Pepine, CJ; Ried, LD | 1 |
| Bakris, GL; Champion, A; Cooper-Dehoff, RM; Kupfer, S; Pepine, CJ; Zhou, Q | 1 |
| Champion, A; Cooper-DeHoff, RM; Handberg, EM; Legler, UF; Mancia, G; Pepine, CJ; Zhou, Q | 1 |
| An, MM; Shi, XY; Wang, L; Xu, FY; Zhang, H; Zou, Z | 1 |
| Akbayram, S; Basaranoglu, M; Caksen, H; Doğan, M; Peker, E; Sahin, M; Uner, A | 1 |
| Bălan, H | 1 |
| Bossi, A; Chiurchiu, C; Cravedi, P; Ene-Iordache, B; Fassi, A; Gaspari, F; Gherardi, G; Iliev, IP; Ilieva, A; Motterlini, N; Perna, A; Remuzzi, G; Rubis, N; Ruggenenti, P; Trevisan, R | 1 |
| Barwina, M; Sein Anand, J; Wiśniewska, A | 1 |
| Castellani, S; Cristofari, C; Di Serio, C; Lambertucci, L; Lotti, E; Marchionni, N; Masotti, G; Torrini, M; Ungar, A | 1 |
| Bavry, AA; Cooper-Dehoff, RM; Gong, Y; Handberg, EM; Khaliq, A; Pepine, CJ | 1 |
| Castro-Serna, D; Escalante-Acosta, BA; Rodríguez-Lopez, L; Rubio-Guerra, AF; Vargas-Ayala, G; Vargas-Robles, H | 1 |
| Brumback, BA; Cooper-Dehoff, RM; Delaney, JA; Gerhard, T; Johnson, JA; Pepine, CJ; Shuster, J; Winterstein, AG | 1 |
| Bossi, A; Capitoni, E; Dodesini, AR; Ene-Iordache, B; Gaspari, F; Iliev, IP; Ilieva, AP; Motterlini, N; Perna, A; Porrini, E; Remuzzi, G; Rubis, N; Ruggenenti, P; Sampietro, G; Trevisan, R | 1 |
| Burkley, B; Cooper-Dehoff, RM; Dominiczak, AF; Gong, Y; Johnson, JA; Langaee, TY; McDonough, CW; Melander, O; Padmanabhan, S; Pepine, CJ | 1 |
| Cooper-Dehoff, RM; Gong, Y; Handberg, EM; Pepine, CJ; Winchester, DE | 1 |
| Linnet, K; Rasmussen, HB; Thomsen, R | 1 |
| Akıllı, NB; Akıncı, E; Gonen, MO; Koylu, R | 1 |
| Bavry, AA; Cooper-DeHoff, RM; Denardo, SJ; Farsang, C; Gong, Y; Handberg, EM; Keltai, M; Mancia, G; Messerli, FH; Pepine, CJ; Szirmai, L | 1 |
| Caran, T; Cibicek, N; Cibickova, L; Dobias, M; Ondra, P; Vorisek, V | 1 |
| Albayrak, B; Bilen, Y; Cankaya, E; Cerrah, S; Cetinkaya, R | 1 |
| Cooper-DeHoff, RM; Gong, Y; Gulati, M; Handberg, E; Huo, T; Merz, CN; Pepine, CJ; Smith, SM | 1 |
| Bavry, AA; Cooper-DeHoff, RM; Elgendy, IY; Gong, Y; Handberg, EM; Pepine, CJ | 1 |
| Bavry, AA; Cooper-DeHoff, RM; Elgendy, IY; Gong, Y; Handberg, EM; Pepine, CJ; Smith, SM; Wokhlu, A | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Johnson, JA; Kubo, M; Magvanjav, O; McDonough, CW; Pepine, CJ; Tanaka, T; Turner, ST | 1 |
| Fares, NV; Farouk, M; Hemdan, A; Magdy, R | 1 |
| Chen, YE; Cooper-DeHoff, RM; Gong, Y; Handberg, EM; Keeley, EC; Pepine, CJ; Sava, RI; Smith, SM | 1 |
| Morris, RL; Scantlebury, DC | 1 |
| Cooper-DeHoff, RM; Dasa, O; Gong, Y; Handberg, E; Howard, G; Pepine, CJ; Smith, SM | 1 |
20 review(s) available for verapamil and trandolapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Diabetes Mellitus, Experimental; Dogs; Drug Therapy, Combination; Hypertension; Indoles; Rats; Rats, Inbred SHR; Rats, Zucker; Swine; Verapamil | 1997 |
Safety profile of the combination of verapamil and trandolapril.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Hypertension; Indoles; Verapamil | 1997 |
Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group).
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Heart Failure; Humans; Indoles; Myocardial Infarction; Verapamil | 1997 |
Combination treatment in hypertension: the VeraTran Study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Indoles; Verapamil | 1997 |
Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Indoles; Myocardial Infarction; Myocardial Ischemia; Recurrence; Verapamil | 1998 |
Fixed combination verapamil SR/trandolapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Delayed-Action Preparations; Drug Combinations; Humans; Indoles; Verapamil | 1998 |
[Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Drug Tolerance; Humans; Hypertension; Indoles; Patient Compliance; Time Factors; Vasodilator Agents; Verapamil | 1999 |
The fixed combination of verapamil SR/trandolapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Drug Combinations; Humans; Hypertension; Indoles; Verapamil | 2000 |
Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Drug Combinations; Humans; Hypertension; Indoles; MEDLINE; Randomized Controlled Trials as Topic; Treatment Outcome; Verapamil | 2002 |
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil | 2002 |
Trandolapril: a newer angiotensin-converting enzyme inhibitor.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Drug Combinations; Heart Failure; Humans; Hypertension; Indoles; Myocardial Infarction; Treatment Outcome; Vasodilator Agents; Verapamil | 2003 |
Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Drug Combinations; Drug Interactions; Humans; Hypertension; Indoles; Liver Failure; Randomized Controlled Trials as Topic; Renal Insufficiency; Verapamil | 2005 |
[Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Perindopril; Placebos; Risk Factors; Surveys and Questionnaires; Time Factors; Vasodilator Agents; Verapamil | 2005 |
Verapamil toxicity: an unusual case report and review of the literature.
Topics: Accidents; Antihypertensive Agents; Calcium Channel Blockers; Drug Combinations; Drug Overdose; Female; Forensic Toxicology; Humans; Hypercholesterolemia; Hypertension; Indoles; Kidney Failure, Chronic; Middle Aged; Verapamil | 2007 |
Trandolapril/verapamil combination in hypertensive diabetic patients.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Indoles; Treatment Outcome; Verapamil | 2007 |
Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Hypertension; Indoles; Treatment Outcome; Verapamil | 2007 |
Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypertension; Indoles; Middle Aged; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Sympathetic Nervous System; Verapamil | 2008 |
Tarka® (trandolapril/verapamil hydrochloride extended-release) overdose.
Topics: Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Overdose; Emergency Treatment; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Risk Assessment; Severity of Illness Index; Treatment Outcome; Verapamil | 2011 |
Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trials.
Topics: Albuminuria; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Kidney; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Verapamil | 2011 |
74 trial(s) available for verapamil and trandolapril
| Article | Year |
|---|---|
Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Carbohydrate Metabolism; Chlorthalidone; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Prospective Studies; Verapamil | 1996 |
Antihypertensive efficacy of a once a day verapamil SR/trandolapril combination.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Single-Blind Method; Verapamil | 1996 |
Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Safety; Verapamil | 1997 |
Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Denmark; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Myocardial Infarction; Recurrence; Time Factors; Verapamil | 1997 |
Cardiovascular effects of a trandolapril/verapamil combination in patients with mild to moderate essential hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular System; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Time Factors; Verapamil | 1997 |
Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Verapamil | 1997 |
Once-daily fixed dose combinations of verapamil and trandolapril in black patients with mild to moderate hypertension: a new choice for first line treatment.
Topics: Adult; Aged; Antihypertensive Agents; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Patient Compliance; Verapamil | 1997 |
Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Verapamil | 1997 |
Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Verapamil | 1997 |
Combination treatment in hypertension: the VeraTran Study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Indoles; Verapamil | 1997 |
Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial.
Topics: Adult; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diuretics; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Indoles; Myocardial Infarction; Stroke Volume; Verapamil | 1997 |
The treatment of severe hypertension with trandolapril, verapamil, and hydrochlorothiazide. Trandolapril/Verapamil Multicenter Study Group.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Safety; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Treatment Outcome; Verapamil | 1997 |
Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Indoles; Myocardial Infarction; Myocardial Ischemia; Recurrence; Verapamil | 1998 |
Primary prevention of renal failure in diabetic patients: the Bergamo Nephrologic Diabetes Complication Trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Combinations; Humans; Indoles; Kidney Failure, Chronic; Prospective Studies; Verapamil | 1998 |
Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Single-Blind Method; Treatment Outcome; Verapamil | 1998 |
Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Humans; Hypertension; Indoles; Male; Multivariate Analysis; Verapamil | 1998 |
Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta; Blood Pressure; Bradycardia; Calcium Channel Blockers; Cough; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Metoprolol; Middle Aged; Sodium Chloride Symporter Inhibitors; Verapamil | 1998 |
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Synergism; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Proteinuria; Verapamil | 1998 |
Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Prospective Studies; Research Design; Treatment Outcome; Verapamil | 1998 |
[The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Prospective Studies; Verapamil | 1998 |
Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient. German VeraTran Hypertension Study Group.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Treatment Outcome; Verapamil | 1999 |
Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Indoles; Kidney Diseases; Male; Middle Aged; Proteinuria; Pulse; Verapamil | 1999 |
Changes in arterial structure and function under trandolapril-verapamil combination in hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Aorta, Abdominal; Blood Pressure; Brachial Artery; Carotid Artery, Common; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Ultrasonography; Vasodilator Agents; Verapamil | 1999 |
Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Attitude to Health; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diastole; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Prospective Studies; Verapamil | 1999 |
Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Renin; Treatment Outcome; Vasodilator Agents; Verapamil | 2000 |
Evaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Confidence Intervals; Cross-Over Studies; Delayed-Action Preparations; Drug Combinations; Electrolytes; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lipoproteins; Male; Middle Aged; Treatment Outcome; Vasodilator Agents; Verapamil | 2000 |
Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Diet, Sodium-Restricted; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Monitoring, Physiologic; Proteinuria; Time Factors; Verapamil | 2001 |
Effective blood pressure treatment improves LDL-cholesterol susceptibility to oxidation in patients with essential hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Malondialdehyde; Middle Aged; Nifedipine; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Verapamil | 2001 |
Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
Topics: Aged; Albuminuria; Analysis of Variance; Antihypertensive Agents; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Spain; Treatment Outcome; Verapamil | 2001 |
Dissociation between blood pressure reduction and fall in proteinuria in primary renal disease: a randomized double-blind trial.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium; Calcium Channel Blockers; Creatinine; Double-Blind Method; Female; Heart Rate; Humans; Indoles; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Serum Albumin; Spain; Verapamil | 2002 |
[Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study].
Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lipids; Losartan; Male; Middle Aged; Prospective Studies; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Treatment Outcome; Vasodilator Agents; Verapamil | 2002 |
[Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Indoles; Lipids; Prospective Studies; Verapamil | 2002 |
Metabolic effects of combined antihypertensive treatment in patients with essential hypertension.
Topics: Antihypertensive Agents; Atenolol; Blood Glucose; Cholesterol; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucose Tolerance Test; Hemodynamics; Humans; Hypertension; Indoles; Insulin; Insulin Secretion; Male; Middle Aged; Nifedipine; Verapamil | 2002 |
Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Biomarkers; Blood Glucose; Blood Pressure; Chlorthalidone; Diabetes Mellitus, Type 2; Diastole; Diuretics; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Patient Compliance; Systole; Treatment Outcome; Vasodilator Agents; Verapamil | 2003 |
The verapamil versus amlodipine in nondiabetic nephropathies treated with trandolapril (VVANNTT) study.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Hemodynamics; Humans; Indoles; Male; Middle Aged; Prospective Studies; Proteinuria; Safety; Treatment Outcome; Verapamil | 2003 |
The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Glomerular Filtration Rate; Humans; Indoles; Male; Middle Aged; Research Design; Verapamil | 2003 |
Verapamil reverts acute renal functional impairment induced by angiotensin II converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Creatinine; Drug Antagonism; Female; Glomerular Filtration Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Prospective Studies; Treatment Outcome; Verapamil | 2003 |
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Treatment Outcome; Verapamil | 2003 |
Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Prospective Studies; Systole; Time Factors; Treatment Outcome; Verapamil | 2004 |
The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Body Weight; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Heart Rate; Humans; Indoles; Infant, Newborn; Male; Middle Aged; Proteinuria; Reference Values; Verapamil | 2004 |
Preventing microalbuminuria in type 2 diabetes.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Proportional Hazards Models; Treatment Outcome; Verapamil | 2004 |
BENEDICT in the treatment of hypertension.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Indoles; Treatment Outcome; Verapamil | 2005 |
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Prospective Studies; Treatment Outcome; Verapamil | 2005 |
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Body Mass Index; Calcium Channel Blockers; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hispanic or Latino; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertrophy, Left Ventricular; Indoles; Ischemic Attack, Transient; Male; Myocardial Revascularization; Residence Characteristics; Risk Factors; Stroke; Systole; Verapamil | 2006 |
Efficacy of a fixed-dose combination of trandolapril-verapamil in obese hypertensive patients resistant to monotherapy.
Topics: Aged; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Female; Humans; Hypertension; Indoles; Male; Mexico; Middle Aged; Obesity; Vasodilator Agents; Verapamil | 2006 |
Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Proportional Hazards Models; Verapamil | 2006 |
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome.
Topics: Adult; Antihypertensive Agents; Blood Glucose; Body Mass Index; Body Size; Body Weight; Drug Therapy, Combination; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypertension; Indoles; Male; Metabolic Syndrome; Middle Aged; Patient Selection; Verapamil | 2006 |
Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
Topics: Adult; Aged; Antihypertensive Agents; Appetite Depressants; Blood Pressure; Body Weight; Cyclobutanes; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Felodipine; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Metoprolol; Middle Aged; Obesity; Prospective Studies; Ramipril; Treatment Outcome; Verapamil | 2007 |
A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Canada; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Primary Health Care; Prospective Studies; Verapamil | 2007 |
Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Confounding Factors, Epidemiologic; Coronary Artery Disease; Drug Therapy, Combination; Female; Gene Frequency; Genotype; Humans; Hypertension; Indoles; Male; Middle Aged; Polymorphism, Genetic; Puerto Rico; Receptor, Angiotensin, Type 1; Treatment Outcome; United States; Verapamil | 2007 |
Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Verapamil | 2007 |
Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study.
Topics: Aged; Blood Pressure Determination; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Probability; Proportional Hazards Models; Prospective Studies; Reference Values; Risk Factors; Treatment Outcome; Verapamil | 2007 |
KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).
Topics: Aged; Antihypertensive Agents; Base Sequence; Calcium Channel Blockers; DNA Primers; Female; Genotype; Humans; Hypertension; Indoles; Large-Conductance Calcium-Activated Potassium Channel beta Subunits; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Verapamil | 2007 |
[Value of fixed combination of verapamil CP/trandolapril in the treatment of patients with metabolic syndrome. Results of the STAR Trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Indoles; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome; Verapamil | 2007 |
Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.
Topics: Analysis of Variance; Chi-Square Distribution; Diabetes Mellitus; Diuretics; Female; Glucose Tolerance Test; Humans; Hydrochlorothiazide; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Metabolic Syndrome; Middle Aged; Renin-Angiotensin System; Verapamil | 2008 |
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Heart Rate; Humans; Hypertension; Indoles; Male; Treatment Outcome; Verapamil | 2008 |
Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients.
Topics: Adult; Antihypertensive Agents; Appetite Depressants; Blood Pressure; Body Weights and Measures; C-Reactive Protein; Cyclobutanes; Delayed-Action Preparations; Diet; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indoles; Lipids; Male; Nicotinamide Phosphoribosyltransferase; Obesity; Verapamil | 2008 |
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Calcium Channel Blockers; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Single-Blind Method; Stroke; Verapamil | 2008 |
The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cell Adhesion Molecules; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Combinations; E-Selectin; Female; Humans; Hypertension; Indoles; Intercellular Adhesion Molecule-1; Male; Middle Aged; Vascular Cell Adhesion Molecule-1; Verapamil | 2008 |
Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Synergism; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Prospective Studies; Proteinuria; Treatment Outcome; Verapamil | 2008 |
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients.
Topics: Acetylcholine; Adult; Antihypertensive Agents; Case-Control Studies; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Indoles; Male; Middle Aged; Nitroprusside; Oxidative Stress; Regional Blood Flow; Vasodilator Agents; Verapamil | 2009 |
Systolic blood pressure and subjective well-being in patients with coronary artery disease.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Mental Health; Middle Aged; Odds Ratio; Quality of Life; Risk Assessment; Risk Factors; Surveys and Questionnaires; Systole; Time Factors; Treatment Outcome; Verapamil | 2009 |
Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Verapamil | 2007 |
Bedtime versus at awakening administration of BP lowering drugs--is it the way to success?
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Cohort Studies; Drug Chronotherapy; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Treatment Outcome; Verapamil | 2009 |
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Prospective Studies; Treatment Outcome; Verapamil | 2011 |
Trandolapril, but not verapamil nor their association, restores the physiological renal hemodynamic response to adrenergic activation in essential hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Female; Glomerular Filtration Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Renal Circulation; Renal Plasma Flow, Effective; Stress, Psychological; Sympathetic Nervous System; Translational Research, Biomedical; Verapamil | 2011 |
Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
Topics: Adiponectin; Aged; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Treatment Outcome; Verapamil | 2011 |
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Confounding Factors, Epidemiologic; Coronary Artery Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Models, Structural; Proportional Hazards Models; Risk Factors; Treatment Outcome; Verapamil | 2012 |
Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Humans; Indoles; Longitudinal Studies; Male; Middle Aged; Risk Factors; Verapamil | 2012 |
Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Case-Control Studies; Coronary Artery Disease; DNA; Factor V; Female; Follow-Up Studies; Genotype; Glycoproteins; Humans; Hypertension; Immunoglobulins; Indoles; Lectins; Male; Membrane Proteins; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Prognosis; Selectins; Treatment Outcome; Verapamil | 2013 |
Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST).
Topics: Age Factors; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chi-Square Distribution; Coronary Artery Disease; Female; Humans; Hypertension; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; United States; Verapamil | 2013 |
Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Coronary Artery Disease; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Monitoring, Ambulatory; Photoperiod; Prospective Studies; Verapamil | 2015 |
Long-Term Mortality in Hypertensive Patients With Coronary Artery Disease: Results From the US Cohort of the International Verapamil (SR)/Trandolapril Study.
Topics: Aged; Blood Pressure Determination; Cause of Death; Comorbidity; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Internationality; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Survival Rate; Systole; Treatment Outcome; United States; Verapamil | 2016 |
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aldehyde Dehydrogenase 1 Family; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Chi-Square Distribution; Drug Combinations; Drug Resistance; Female; Florida; Genome-Wide Association Study; Georgia; Humans; Hydrochlorothiazide; Hypertension; Indoles; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pharmacogenetics; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Prospective Studies; Retinal Dehydrogenase; Risk Factors; Sodium Chloride Symporter Inhibitors; Treatment Outcome; Vasodilator Agents; Verapamil; Young Adult | 2017 |
59 other study(ies) available for verapamil and trandolapril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Basilar Artery; Blood Pressure; Cerebrovascular Circulation; Disease Models, Animal; Endothelins; Enzyme Inhibitors; Hypertension; Image Processing, Computer-Assisted; Indoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Serotonin; Vasodilator Agents; Verapamil; Video Recording | 1995 |
L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta; Arginine; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Indoles; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Vasoconstriction; Vasodilator Agents; Verapamil | 1995 |
Endothelial dysfunction in aorta of the spontaneously hypertensive, stroke-prone rat: effects of therapy with verapamil and trandolapril alone and in combination.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cerebrovascular Disorders; Drug Administration Schedule; Drug Therapy, Combination; Endothelium, Vascular; Hypertension; Indoles; Male; Muscle Contraction; Nitric Oxide; Norepinephrine; Rats; Rats, Inbred SHR; Verapamil | 1994 |
Effects of treatment of spontaneously hypertensive rats with the angiotensin-converting enzyme inhibitor trandolapril and the calcium antagonist verapamil on the sensitivity of glucose metabolism to insulin in rat soleus muscle in vitro.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium Channel Blockers; Glucose; Glycogen; Humans; In Vitro Techniques; Indoles; Insulin; Lactates; Male; Muscle, Skeletal; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Verapamil | 1996 |
[Effect of chronic inhibition of nitric oxide synthesis on vascular structure: remodeling or growth?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Basilar Artery; Blood Pressure; Disease Models, Animal; Endothelium, Vascular; Hypertension; Indoles; Muscle Development; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Verapamil | 1995 |
Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Pressure; Body Weight; Endothelium, Vascular; Heart Rate; Indoles; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Renal Artery; Time Factors; Vasoconstriction; Vasodilation; Verapamil | 1996 |
Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Calcium Channel Blockers; Female; Glucose; Indoles; Insulin Resistance; Muscle, Skeletal; Obesity; Rats; Rats, Zucker; Verapamil | 1996 |
Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Ventricular Dysfunction, Left; Ventricular Function, Left; Verapamil | 1996 |
Individual and combined effects of verapamil or trandolapril on attenuating hypertensive glomerulopathic changes in the stroke-prone rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Creatinine; Disease Progression; Disease Susceptibility; Drug Synergism; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Hypertension; Indoles; Kidney; Male; Metabolic Clearance Rate; Proteinuria; Rats; Rats, Inbred SHR; Verapamil | 1996 |
Trandolapril plus verapamil inhibits the coronary vasospasm induced by hypoxia following ischemia-reperfusion injury in dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Coronary Vasospasm; Dogs; Drug Therapy, Combination; Female; Hypoxia; Indoles; Male; Myocardial Reperfusion Injury; Verapamil | 1996 |
NOS activity in skeletal muscle from hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Hypertension; Indoles; Insulin Resistance; Muscle, Skeletal; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Verapamil | 1997 |
Renal effects of antihypertensive therapy in uninephrectomized diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Hemodynamics; Indoles; Kidney; Kidney Function Tests; Nephrectomy; Rats; Rats, Wistar; Streptozocin; Verapamil | 1997 |
Renal changes induced by nitric oxide and prostaglandin synthesis reduction: effects of trandolapril and verapamil.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Indoles; Kidney; Male; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandin Antagonists; Renal Circulation; Verapamil | 1998 |
[Obesity in the service of Justice. New drug-combination leads to protection of the kidney].
Topics: Antihypertensive Agents; Calcium Channel Blockers; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Diabetic; Female; Humans; Hypertension; Indoles; Middle Aged; Obesity; Verapamil | 1997 |
Antihypertensive action of trandolapril and verapamil in spontaneously hypertensive rats after unilateral nephrectomy.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Female; Heart; Hypertension; Indoles; Nephrectomy; Nitroprusside; Norepinephrine; Potassium Chloride; Rats; Rats, Inbred SHR; Vasoconstriction; Vasodilator Agents; Verapamil | 1998 |
Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antigens, CD; Aorta, Thoracic; Arteries; Blood Pressure; Body Weight; Calcium Channel Blockers; Carotid Arteries; Fibronectins; Heart Rate; Hypertension; Hypertrophy; Indoles; Integrin alpha5; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vascular Diseases; Verapamil | 1998 |
[Isoptin. Evolution of views from Fleckenstein to the present days].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Coronary Vessels; Drug Combinations; Drug Evaluation; Heart Rate; History, 20th Century; Humans; Hypertension; Indoles; Myocardial Contraction; Safety; Treatment Outcome; Vasodilation; Verapamil | 1998 |
Combination of a calcium antagonist, verapamil, with an angiotensin converting enzyme inhibitor, trandolapril, in experimental myocardial ischemia and reperfusion: antiarrhythmic and hemodynamic effects of chronic oral pretreatment.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac Output; Hemodynamics; Indoles; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Premedication; Swine; Time Factors; Ventricular Function, Left; Verapamil | 1998 |
Antihypertensive effect of trandolapril and verapamil in rats with induced hypertension.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Body Weight; Drug Synergism; Female; Hypertension; In Vitro Techniques; Indoles; Infarction; Kidney; Ligation; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Verapamil | 1999 |
Mesenteric cyclooxygenase products after combined antihypertensive treatment in uninephrectomized SHRs.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Hypertension; Indoles; Indomethacin; Mesenteric Arteries; Myocardial Contraction; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred SHR; Verapamil | 2000 |
How can hypertensive patients be better treated? The contribution of combination therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cohort Studies; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Risk Factors; Verapamil | 2000 |
The effects of anti-hypertensive therapy on the structural, mechanical and metabolic properties of the rat aorta.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Hypertension; Indoles; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilator Agents; Verapamil | 2000 |
[ACE inhibitor and calcium channel blocker in a fixed combination. Lowering blood pressure in diabetic patients].
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indoles; Verapamil | 2000 |
[Accomplishing 2 goals at once. Nephropathy and cardiac risk].
Topics: Antihypertensive Agents; Coronary Disease; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension, Renal; Indoles; Verapamil | 2000 |
[Diabetic nephropathy with nephrotic syndrome--apropos of 2 cases. Advantages of combined conversion enzyme inhibitor and non-dihydropyridine calcium antagonist treatment].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Humans; Indoles; Kidney Function Tests; Male; Middle Aged; Nephrotic Syndrome; Verapamil | 2000 |
High-dose verapamil-trandolapril induced rhabdomyolysis and acute renal failure.
Topics: Acute Kidney Injury; Adult; Antihypertensive Agents; Calcium Channel Blockers; Creatine Kinase; Dose-Response Relationship, Drug; Humans; Indoles; Male; Rhabdomyolysis; Verapamil | 2000 |
High-dose verapamil + trandolapril-induced thrombotic microangiopathy.
Topics: Adult; Anemia, Hemolytic; Blood Cell Count; Drug Overdose; Female; Hematocrit; Hemoglobins; Humans; Indoles; Microcirculation; Thrombocytopenia; Time Factors; Verapamil | 2002 |
Calcium antagonist strategies for coronary artery disease.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Diastole; Humans; Hydrochlorothiazide; Indoles; Randomized Controlled Trials as Topic; Systole; Verapamil | 2004 |
VISP and INVEST.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Coronary Disease; Homocysteine; Humans; Hypertension; Indoles; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Verapamil; Vitamins | 2004 |
[Antihypertensive drug tarka (trandolapril plus verapamil) - unique fixed dose combination].
Topics: Aged; Drug Administration Schedule; Drug Combinations; Female; Humans; Hypertension; Indoles; Male; Verapamil | 2004 |
Managing hypertension in European patients with coronary artery disease: design, results, and clinical implications of INVEST.
Topics: Antihypertensive Agents; Coronary Disease; Drug Therapy, Combination; Europe; Humans; Hypertension; Indoles; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design; Verapamil | 2004 |
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Verapamil | 2004 |
[Lethal polypharmacy in a patient with arterial hypertension].
Topics: Aged; Aged, 80 and over; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cerebral Infarction; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Hypotension; Indoles; Male; Polypharmacy; Sodium Chloride Symporter Inhibitors; Timolol; Tomography, X-Ray Computed; Verapamil | 2004 |
[Characteristic features of the pathogenesis and treatment of coronary heart diseases, heart failure and arterial hypertension in patients with diabetes mellitus].
Topics: Adrenergic beta-Antagonists; Adult; Aspirin; Blood Glucose; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Diuretics; Female; Glycated Hemoglobin; Heart Failure; Humans; Hypertension; Hypolipidemic Agents; Indoles; Male; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Sex Factors; Verapamil | 2005 |
A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients.
Topics: Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chi-Square Distribution; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Treatment Outcome; Verapamil | 2005 |
Predictors of adverse outcome among patients with hypertension and coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Humans; Hypertension; Indoles; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke; Verapamil | 2006 |
Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Case-Control Studies; Cohort Studies; Coronary Disease; Delayed-Action Preparations; Female; Hispanic or Latino; Humans; Hypertension; Indoles; Male; Middle Aged; Randomized Controlled Trials as Topic; Systole; Treatment Outcome; Verapamil | 2006 |
Prevention of microalbuminuria in type 2 diabetes: millimeters or milligrams?
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indoles; Verapamil | 2006 |
Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Black People; Coronary Artery Disease; Databases, Factual; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Stroke; United States; Verapamil | 2008 |
Bromide as marker for drug adherence in hypertensive patients.
Topics: Adolescent; Aged; Antihypertensive Agents; Blood Pressure; Bromides; Calcium Channel Blockers; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Patient Compliance; Potassium Compounds; Verapamil | 2008 |
[Effectiveness and safety of administration of trandolapril/verapamil combination preparation as initial therapy in patients with arterial hypertension and thickening of intima-media complex of carotid arteries].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Carotid Arteries; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Randomized Controlled Trials as Topic; Tunica Intima; Tunica Media; Ultrasonography; Vasodilator Agents; Verapamil | 2008 |
Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy.
Topics: Aged; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Artery Disease; Female; Humans; Hypertension; Incidence; Indoles; Male; Middle Aged; Prevalence; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Verapamil | 2009 |
INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Coronary Artery Disease; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Randomized Controlled Trials as Topic; Verapamil | 2009 |
Tarka® overdose in a young child.
Topics: Child, Preschool; Drug Combinations; Drug Overdose; Electrocardiography; Female; Humans; Indoles; Pacemaker, Artificial; Treatment Outcome; Verapamil | 2011 |
[The lower legs amputation--rare side effects of acute poisoning].
Topics: Amputation, Surgical; Drug Combinations; Drug Overdose; Ethanol; Humans; Indoles; Ischemia; Leg; Male; Middle Aged; Suicide, Attempted; Verapamil | 2010 |
Harmful effects of NSAIDs among patients with hypertension and coronary artery disease.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; Celecoxib; Confounding Factors, Epidemiologic; Coronary Artery Disease; Diclofenac; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Ibuprofen; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Myocardial Infarction; Naproxen; Odds Ratio; Proportional Hazards Models; Pyrazoles; Randomized Controlled Trials as Topic; Stroke; Sulfonamides; Verapamil | 2011 |
In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Carboxylesterase; Carboxylic Ester Hydrolases; Diltiazem; Drug Interactions; Enalapril; Esters; Humans; Hydrolysis; Inactivation, Metabolic; Indoles; Kinetics; Liver; Microsomes, Liver; Nitrophenols; Prodrugs; Ramipril; Recombinant Proteins; Verapamil | 2014 |
Successful resuscitation of a patient with continuous venovenous hemodiafiltration following intoxication from verapamil and trandolapril.
Topics: Adult; Female; Hemofiltration; Humans; Indoles; Resuscitation; Tomography, X-Ray Computed; Verapamil | 2014 |
Multi-drug intoxication fatality involving atorvastatin: A case report.
Topics: Acute Kidney Injury; Aged; Alcoholics; Anthraquinones; Anti-Inflammatory Agents; Antihypertensive Agents; Atorvastatin; Drug Overdose; Female; Forensic Toxicology; Gastrointestinal Contents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Piperazines; Rhabdomyolysis; Suicide; Vasodilator Agents; Verapamil | 2015 |
The effects of dual and triple combinations of trandolapril, telmisartan, and verapamil on overt proteinuria in the patients with diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Proteinuria; Telmisartan; Verapamil; Young Adult | 2016 |
Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women's Heart Disease.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Coronary Artery Disease; Drug Resistance; Female; Humans; Hypertension; Indoles; Middle Aged; Myocardial Ischemia; Obesity; Prospective Studies; Risk Factors; Stroke; Treatment Outcome; United States; Verapamil | 2016 |
Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Coronary Artery Disease; Diastole; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Systole; Time Factors; United States; Verapamil | 2018 |
Univariate calibrations with or without chemometric assistance for determination of drugs lacking peak maxima in their zero-order profiles.
Topics: Area Under Curve; Calibration; Drug Combinations; Indoles; Least-Squares Analysis; Limit of Detection; Linear Models; Reproducibility of Results; Spectrophotometry; Verapamil | 2019 |
Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Coronary Artery Disease; Female; Humans; Hypertension; Indoles; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Treatment Outcome; Verapamil | 2020 |
Hypertension and Coronary Artery Disease in Women: Is Aggressive Blood Pressure Control Appropriate?
Topics: Blood Pressure; Coronary Artery Disease; Female; Humans; Hypertension; Indoles; Verapamil | 2020 |
Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Coronary Artery Disease; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Proportional Hazards Models; Randomized Controlled Trials as Topic; Sex Factors; Verapamil | 2021 |